II
AERI

Inspire Investing’s Aerie Pharmaceuticals AERI Stock Holding History

Inspire Investing’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-14,652
Closed -$235K – 965
2021
Q2 		$235K Buy
14,652
+444
+3% +$7.62K 0.03% 570
2021
Q1 		$254K Sell
14,208
-1,230
-8% -$21.2K 0.04% 557
2020
Q4 		$209K Buy
15,438
+2,478
+19% +$29.9K 0.05% 607
2020
Q3 		$153K Buy
+12,960
New +$158K 0.04% 405
2018
Q1 		– Sell
-965
Closed -$58K – 776
2017
Q4 		$58K Buy
+965
New +$58.5K 0.05% 430

Other funds holding AERI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Inspire Investing's AERI Position: Q3 2021 in Review

Inspire Investing sold out of Aerie Pharmaceuticals (AERI) in Q3 2021, closing a stake of 14,652 shares — an estimated $235K sold.

Inspire Investing first reported a position in AERI in Q4 2017 and held it in 5 quarters. The position peaked at $254K in Q1 2021. 137 funds tracked by Wall St. Rank hold AERI as of Q3 2021.

  • Inspire Investing reported no remaining Aerie Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Inspire Investing sold 14,652 Aerie Pharmaceuticals shares in Q3 2021, an estimated $235K.
  • Inspire Investing first reported a position in Aerie Pharmaceuticals in Q4 2017 and held it in 5 quarters.
  • Inspire Investing's Aerie Pharmaceuticals position peaked at $254K in Q1 2021.
  • 137 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2021.

Based on Inspire Investing's 13F filing for Q3 2021, filed 9 Nov 2021.